We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Safety Monitoring of Novavax COVID-19 Vaccine Among Persons Aged ≥12 Years -- United States, July 13, 2022-March 13, 2023.
- Authors
Romanson, Brittney; Moro, Pedro L.; Su, John R.; Marquez, Paige; Nair, Narayan; Day, Brendan; DeSantis, Allison; Shimabukuro, Tom T.
- Abstract
The article presents a safety monitoring study of the Novavax COVID-19 vaccine among individuals aged 12 years and older in the United States from July 13, 2022, to March 13, 2023. It mentions that the study analyzed adverse events reported after administration of the vaccine, with no new safety concerns identified, and emphasized the importance of proper vaccine administration and education to prevent errors.
- Subjects
UNITED States; COVID-19 vaccines; NOVAVAX Inc.; ADVERSE health care events; MEDICAL errors
- Publication
MMWR: Morbidity & Mortality Weekly Report, 2023, Vol 72, Issue 31, p850
- ISSN
0149-2195
- Publication type
Article
- DOI
10.15585/mmwr.mm7231a4